Myrexis, Inc. (MYRX)

OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Jan 21, 2026
-94.29%
Market Cap13.79K
Revenue (ttm)n/a
Net Income (ttm)-11.62M
Shares Out34.48M
EPS (ttm)-0.39
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100
Average Volume147,126
Open0.0004
Previous Closen/a
Day's Range0.0004 - 0.0004
52-Week Range0.0001 - 0.0080
Beta4.01
RSI40.40
Earnings Daten/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. [Read more]

Sector Financials
CEO Jonathan Couchman
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MYRX
Full Company Profile